Clinical trial
Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle…
NCT00372827 · Alcon Research, Industry · Completed
Key facts
| NCT number | NCT00372827 |
|---|---|
| Title | Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension |
| Official title | Efficacy and Safety of Timolol Maleate 0.5% Compared to Brinzolamide 1% When Added to Travoprost 0.004% in Primary Open-angle Glaucoma or Ocular Hypertension |
| Lead sponsor | Alcon Research, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Primary Open-angle Glaucoma, Ocular Hypertension, Pigment Dispersion Glaucoma |
| Intervention type | Drug |
| Interventions | Brinzolamide 1% added to Travoprost 0.004% |
| Enrollment | 245 |
| Start date | Feb 1, 2004 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Sep 7, 2006 |
| Last update posted | Nov 21, 2016 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: